Jiayong Liu*, Tian Gao*, Zhichao Tan*, Shu Li, Jie Xu, Chujie Bai, Ruifeng Xue, Lu Xie, Lu Zhang, Zhengfu Fan#, Wei Guo#. Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma.,Clinical Cancer Research.,2022. 28(16):3473-3479

Chaohu Pan*, Qiaomei Cai*, Xiaorong Li, Lili Li, Liping Yang, Yu Chen, Junxiao Liu, Wancheng Liu, Meiling Gao, Tianqi Sui, Xiaoyang Wang, Huiming Fan, Jiayin Ruan, Yueyue Shi, Saihua Chen, Lucy S Cheng, Jiayong Liu #, Heng Yang #, Genhong Cheng#. Enhancing the HSV-1-mediated antitumor immune response by suppressing Bach1.,Cellular & Molecular Immunology,2022. 19(4):516-526

Zhichao Tan*, Jiayong Liu*#, Ruifeng Xue?, Zhengfu Fan, Chujie Bai, Shu Li, Tian Gao, Lu Zhang and Xinyu Wang. Clinical features and therapeutic outcomes of alveolar soft part sarcoma in children: A single-center, retrospective study.,Frontiers in Oncology,12:1019911. doi: 10.3389/fonc.2022.1019911.

Yuxing Huang*, Jing Su*, Jiayong Liu*, Xin Yi, Fang Zhou, Jiaran Zhang, Jiaxiang Wang, Xuan Meng, Lu Si #, Congying Wu #. YAP Activation in Promoting Negative Durotaxis and Acral Melanoma Progression.,Cells,2022. 11(22):3543. doi: 10.3390/cells11223543.

Jiayong Liu* #, Peijie Liu, Fuyu Gong, Youhui Tian, Xiaochen Zhao. Case Report: A PD-L1-Positive Patient With Pleomorphic Rhabdomyosarcoma Achieving an Impressive Response to Immunotherapy.,Frontiers in Immunology.,2022. 17;13:815598

Zhichao Tan, Xinyu Wang#, Jiayong Liu# *, Zhengfu Fan, Tian Gao, Chujie Bai, Ruifeng Xue, Shu Li, Lu Zhang. Efficacy of PD-1 inhibitors combined with pegylated liposomal doxorubicin and dacarbazine compared with liposomal doxorubicin and dacarbazine in advanced leiomyosarcoma patients：a retrospective, single-institutional cohort study.,Annals of Translational Medicine.,2022,10(18):1000.

Jiayong Liu* #, Zhichao Tan*, Ruifeng Xue*, Zhengfu Fan, Chujie Bai, Shu Li, Tian Gao, Lu Zhang, Zhiwei Fang, Lu Si #. The efficacy of Tc-99m- rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients.,Annals of Translational Medicine,2022. 10(2):95. doi: 10.21037/atm-21-6890.

Jiayong Liu* #, Zhengfu Fan, Chujie Bai, Shu Li, Ruifeng Xue, Tian Gao, Lu Zhang, Zhichao Tan, Zhiwei Fang. Real-world experience with pembrolizumab in patients with advanced soft tissue sarcoma.,Annals of Translational Medicine,2021. 9(4):339. doi: 10.21037/atm-21-49.

Jiayong Liu*, Zhengfu Fan*, Marc El Beaino, Valerae O Lewis, Bryan S Moon, Robert L Satcher, Justin E Bird, Spencer J Frink, Patrick P Lin #. Surgical drainage after limb salvage surgery and endoprosthetic reconstruction: is 30 mL/day critical?,Journal of Orthopaedic Surgery and Research,2021. 15;16(1):137. doi: 10.1186/s13018-021-02276-x.

Jiayong Liu* #, Zhengfu Fan, Shu Li, Tian Gao, Ruifeng Xue, Chujie Bai, Lu Zhang, Zhichao Tan, Zhiwei Fang. Target therapy for metastatic alveolar soft part sarcoma: a retrospective study with 47 cases.,Annals of Translational Medicine,2020. 8(22):1493. doi: 10.21037/atm-20-6377.

Marc El Beaino*, Jiayong Liu*, Amanda R Wasylishen, Rasoul Pourebrahim, Agata Migut, Bryan J Bessellieu, Ke Huang, Patrick P Lin #. Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells.,BMC Cancer.,2;20(1):3. doi: 10.1186/s12885-019-6465-8.

Jia-Yong Liu* #, Bao-Rang Zhu, Yu-Dong Wang, Xin Sun. The efficacy and safety of apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis.,International Journal of Clinical Oncology.,2020. 25(6):1195-1205. doi: 10.1007/s10147-020-01644-7.

研究生招生计划

招生年度	招生专业	学位级别	学位类型	研究方向	选拔方式	操作
2025	肿瘤外科学	硕士	专业学位	临床技能训练与研究	全国统考